CDTX - Cidara Therapeutics shares fall as chief scientific officer sells ~18K stock
2023-09-14 10:51:26 ET
More on Cidara Therapeutics
- Seeking Alpha’s Quant Rating on Cidara Therapeutics
- Cidara Therapeutics: Leveraging Antifungals To Move Into Cancer Therapy
- Cidara antifungal drug Rezzayo launched in US by partner Melinta
For further details see:
Cidara Therapeutics shares fall as chief scientific officer sells ~18K stock